Japanese biotechnology company developing and commercializing N-NOSE, a cancer screening test that uses the olfactory abilities of nematodes to detect trace odor compounds in urine
Japanese biotechnology company developing and commercializing N-NOSE, a cancer screening test that uses the olfactory abilities of nematodes to detect trace odor compounds in urine. The test is designed as an accessible, at-home entry point for early cancer risk detection.
The top three firms on F4's Biotech & Life Sciences investor list.